Your English writing platform
Discover LudwigExact(1)
Adenoid cystic carcinoma of the lower respiratory tract is a rare indolent neoplasm with prolonged survival, propensity for recurrences and metastasis years after initial therapy.
Similar(11)
Acinetobacter infections have increased and gained attention because of the organism's prolonged environmental survival and propensity to develop antimicrobial drug resistance [1],[2].
Cox survival and propensity score analyses assessed associations with overall survival.
Hence, miR-203 is a prognostic indicator of overall survival and propensity for metastasis.
Acinetobacter infections have increased and gained attention because of the organism's prolonged environmental survival and propensity to develop antimicrobial drug resistance [ 1],[ 2].
Compared with surgery alone, adjuvant CRT improved survival in propensity score analysis for all patients by 33% (P < .001), with improved survival when stratified by age, margin, node, and T-stage (RR = 0.57 0.75, P < .05).05
In addition, we analyzed the relationship between transport and survival in propensity-matched patients.
To make causal inference on the effect of AC on survival outcomes, a propensity score inverse probability of treatment weighting approach was applied to survival analysis.
Three different but supportive approaches were used: a case control analysis, a time-dependent covariate analysis and a survival analysis after propensity exact matching method.
Several studies have assessed the prognostic value of RANK expression in breast cancer patients regarding survival and the propensity for bone metastases.
Median survival adjusted for propensity score was significantly longer in the home care group (67.0 days, n = 69) than in the hospital care group (33.0 days, n = 69; P = 0.0013).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com